Jörn M. Schattenberg
University Medical Center Mainz of the Johannes Gutenberg University
61 papers found
Refreshing results…
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
UploadInequities in primary liver cancer in Europe: The state of play
UploadGlobal survey of stigma among physicians and patients with nonalcoholic fatty liver disease
UploadMetabolic signatures across the full spectrum of non-alcoholic fatty liver disease
Download from doi.orgA Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH
UploadLiver injury in COVID-19: The current evidence
Download from onlinelibrary.wiley.comImprovement of non-invasive markers of NAFLD from an individualised, web-based exercise program
UploadMissing publications? Search for publications with a matching author name.